These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36695411)

  • 21. Multiple rounds of one sample versus two sample faecal immunochemical test-based colorectal cancer screening: a population-based study.
    Schreuders EH; Grobbee EJ; Nieuwenburg SAV; Kapidzic A; van Roon AHC; van Vuuren AJ; Lansdorp-Vogelaar I; Spijker WWJ; Izelaar K; Bruno MJ; Kuipers EJ; Spaander MCW
    Lancet Gastroenterol Hepatol; 2019 Aug; 4(8):622-631. PubMed ID: 31196734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of COVID-19 on national program of colorectal cancer screening in Tehran, Iran: a multicenter study.
    Sadeghi A; Asadzadeh Aghdaei H; Khalafi MA; Nazemalhosseini-Mojarad E; Ketabi Moghadam P; Sohrabi MR
    BMC Cancer; 2023 Jul; 23(1):627. PubMed ID: 37407931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe.
    Toes-Zoutendijk E; Portillo I; Hoeck S; de Brabander I; Perrin P; Dubois C; van Leerdam M; Lansdorp-Vogelaar I; Bardou M
    J Med Screen; 2020 Jun; 27(2):68-76. PubMed ID: 31645173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prioritisation of colonoscopy services in colorectal cancer screening programmes to minimise impact of COVID-19 pandemic on predicted cancer burden: A comparative modelling study.
    van Wifferen F; de Jonge L; Worthington J; Greuter MJE; Lew JB; Nadeau C; van den Puttelaar R; Feletto E; Yong JHE; Lansdorp-Vogelaar I; Canfell K; Coupé VMH;
    J Med Screen; 2022 Jun; 29(2):72-83. PubMed ID: 35100894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study.
    Nonboe MH; Napolitano G; Schroll JB; Vejborg I; Waldstrøm M; Lynge E
    Elife; 2023 Mar; 12():. PubMed ID: 36943035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colorectal cancer mortality after randomized implementation of FIT-based screening - a nationwide cohort study.
    Njor SH; Larsen MB; Søborg B; Andersen B
    J Med Screen; 2022 Dec; 29(4):241-248. PubMed ID: 35635233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of driving time on participation in colorectal cancer screening with sigmoidoscopy and faecal immunochemical blood test.
    Berthelsen M; Berstad P; Randel KR; Hoff G; Natvig E; Holme Ø; Botteri E
    Cancer Epidemiol; 2022 Oct; 80():102244. PubMed ID: 36057171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study.
    Larsen PT; Jørgensen SF; Njor SH
    BMC Gastroenterol; 2022 May; 22(1):256. PubMed ID: 35596148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Supply and quality of colonoscopy according to the characteristics of gastroenterologists in the French population-based colorectal-cancer screening program.
    Koïvogui A; Vincelet C; Abihsera G; Ait-Hadad H; Delattre H; Le Trung T; Bernoux A; Carroll R; Nicolet J
    World J Gastroenterol; 2023 Mar; 29(9):1492-1508. PubMed ID: 36998423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
    Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM
    Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy.
    Cheng SY; Chen CF; He HC; Chang LC; Hsu WF; Wu MS; Chiu HM
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1614-1619. PubMed ID: 33217055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once-only colonoscopy or two rounds of faecal immunochemical testing 2 years apart for colorectal cancer screening (SCREESCO): preliminary report of a randomised controlled trial.
    Forsberg A; Westerberg M; Metcalfe C; Steele R; Blom J; Engstrand L; Fritzell K; Hellström M; Levin LÅ; Löwbeer C; Pischel A; Strömberg U; Törnberg S; Wengström Y; Ekbom A; Holmberg L; Hultcrantz R;
    Lancet Gastroenterol Hepatol; 2022 Jun; 7(6):513-521. PubMed ID: 35298893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. To do or not to do - a survey study on factors associated with participating in the Danish screening program for colorectal cancer.
    Nielsen JB; Berg-Beckhoff G; Leppin A
    BMC Health Serv Res; 2021 Jan; 21(1):43. PubMed ID: 33413310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Five-year experience of organized colorectal cancer screening in a Swedish population - increased compliance with age, female gender, and subsequent screening round.
    Blom J; Kilpeläinen S; Hultcrantz R; Törnberg S
    J Med Screen; 2014 Sep; 21(3):144-50. PubMed ID: 25070434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.
    de Jonge L; Worthington J; van Wifferen F; Iragorri N; Peterse EFP; Lew JB; Greuter MJE; Smith HA; Feletto E; Yong JHE; Canfell K; Coupé VMH; Lansdorp-Vogelaar I;
    Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):304-314. PubMed ID: 33548185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of colorectal cancer screening backlog due to the COVID-19 pandemic: A retrospective analysis of the use of a colorectal cancer screening clinical-decision support tool in Argentina.
    Pereyra L; Steinberg L; Lasa J; Marconi A; Calderwood AH; Pellisé M
    Gastroenterol Hepatol; 2024 Feb; 47(2):140-148. PubMed ID: 36934841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the COVID-19 Pandemic on the Diagnosis of Colorectal Cancer within a Population-Based Organized Screening Program.
    Cubiella J; Calderón-Cruz B; Almazán R; Gómez-Amorín Á
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of application effects of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in colorectal cancer screening in Xuzhou population].
    Kong YX; Dong D; Chen HD; Dai M; Zhuo L; Lou T; Cai ST; Chen JJ; Pan YH; Gao H; Lu ZM; Dong HY; Zhao XH; Luo GH; Chen G
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Aug; 56(8):1074-1079. PubMed ID: 35922234
    [No Abstract]   [Full Text] [Related]  

  • 39. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 40. Model-Based Estimation of Colorectal Cancer Screening and Outcomes During the COVID-19 Pandemic.
    Issaka RB; Taylor P; Baxi A; Inadomi JM; Ramsey SD; Roth J
    JAMA Netw Open; 2021 Apr; 4(4):e216454. PubMed ID: 33843997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.